Spinelli S, Frenken L G, Hermans P, Verrips T, Brown K, Tegoni M, Cambillau C
Architecture et Fonction des Macromolecules Biologiques, CNRS, UPR-9039, 31 Chemiin Joseph Aiguier, 13402 Marseille Cedex 20, France.
Biochemistry. 2000 Feb 15;39(6):1217-22. doi: 10.1021/bi991830w.
Camelids can produce antibodies devoid of light chains and CH1 domains (Hamers-Casterman, C. et al. (1993) Nature 363, 446-448). Camelid heavy-chain variable domains (VHH) have high affinities for protein antigens and the structures of two of these complexes have been determined (Desmyter, A. et al. (1996) Nature Struc. Biol. 3, 803-811; Decanniere, K. et al. (1999) Structure 7, 361-370). However, the small size of these VHHs and their monomeric nature bring into question their capacity to bind haptens. Here, we have successfully raised llama antibodies against the hapten azo-dye Reactive Red (RR6) and determined the crystal structure of the complex between a dimer of this hapten and a VHH fragment. The surface of interaction between the VHH and the dimeric hapten is large, with an area of ca. 300 A(2); this correlates well with the low-dissociation constant of 22 nM measured for the monomer. The VHH fragment provides an efficient combining site to the RR6, using its three CDR loops. In particular, CDR1 provides a strong interaction to the hapten through two histidine residues bound to its copper atoms. VHH fragments might, therefore, prove to be valuable tools for selecting, removing, or capturing haptens. They are likely to play a role in biotechnology extending beyond protein recognition alone.
骆驼科动物能够产生不含轻链和CH1结构域的抗体(哈默斯 - 卡斯特曼,C.等人(1993年)《自然》363卷,446 - 448页)。骆驼科动物重链可变结构域(VHH)对蛋白质抗原有高亲和力,并且已经确定了其中两种复合物的结构(德斯米特,A.等人(1996年)《自然结构生物学》3卷,803 - 811页;德坎尼尔,K.等人(1999年)《结构》7卷,361 - 370页)。然而,这些VHH的小尺寸及其单体性质使其结合半抗原的能力受到质疑。在此,我们成功制备了针对半抗原偶氮染料活性红(RR6)的羊驼抗体,并确定了该半抗原二聚体与一个VHH片段之间复合物的晶体结构。VHH与二聚体半抗原之间的相互作用表面很大,面积约为300 Ų;这与测得的单体22 nM的低解离常数很好地相关。VHH片段利用其三个互补决定区(CDR)环为RR6提供了一个有效的结合位点。特别是,CDR1通过与其铜原子结合的两个组氨酸残基与半抗原提供了强相互作用。因此,VHH片段可能被证明是用于选择、去除或捕获半抗原的有价值工具。它们可能在生物技术中发挥作用,其作用范围可能超出单纯的蛋白质识别。